WASHINGTON — The U.S. House of Representatives passed landmark legislation on Wednesday to prohibit members of Congress, their spouses, and dependent children from purchasing publicly traded stocks, responding to years of escalating public demand for ethics reform on Capitol Hill.
The measure, known as the Stop Insider Trading Act, aims to eliminate potential conflicts of interest and prevent federal lawmakers from profiting off non-public information gathered through their legislative duties.
Background and Escalating Public Pressure
Congressional stock trading has drawn sharp criticism since the passage of the Stop Trading on Congressional Knowledge (STOCK) Act of 2012.
While the 2012 law mandated public disclosure of equity transactions within 45 days, policy analysts routinely highlighted its weak enforcement mechanisms and nominal fines, which often totaled just $200 for late filings.
Scrutiny reached a critical threshold during the early months of the COVID-19 pandemic, when several lawmakers engaged in multimillion-dollar stock transactions shortly after attending private briefings regarding the emerging health crisis.
More recently, public frustration mounted when members of key banking and financial services committees traded equities during the regional banking collapse in early 2023.
Key Provisions of the Stop Insider Trading Act
The newly passed legislation imposes strict limits on how lawmakers manage their private wealth while holding elected office.
Under the bill, sitting members of Congress, their spouses, and dependent children are banned from buying individual stocks, corporate bonds, commodities, and digital assets.
For assets already owned, lawmakers must choose between complete divestment within 90 days of taking office or transferring holdings into a qualified, independent blind trust.
The legislation explicitly permits investments in broadly diversified mutual funds, exchange-traded funds (ETFs), and U.S. Treasury securities, ensuring members can still invest for retirement without individual stock exposure.
To ensure compliance, the act establishes substantial financial penalties equal to the full market value of any unauthorized purchase, alongside mandatory referrals to the House Ethics Committee.
Expert Perspectives and Public Support
Ethics watchdogs and policy experts widely endorsed the legislative move, framing it as an essential step toward rebuilding institutional trust.
“For far too long, members of Congress have operated under an ethical framework that allowed the perception—and sometimes reality—of insider trading,” said Kedric Payne, Vice President and General Counsel at the Campaign Legal Center.
“This legislation establishes a clear boundary that protects public integrity without hindering a lawmaker’s ability to build personal savings through diversified funds,” Payne added.
Public opinion heavily aligns with the strict measures.
A national survey conducted by the Program for Public Consultation at the University of Maryland found that 86% of registered voters favor banning congressional stock trading, including 88% of Democrats and 85% of Republicans.
Despite broad support, opponents during floor debates argued that mandatory divestment burdens lawmakers with heavy administrative fees and could deter qualified private-sector professionals from running for public office.
Broader Implications and Next Steps
The passage of the bill marks a significant pivot in Capitol Hill culture, setting a elevated benchmark for legislative accountability.
Attention now turns to the U.S. Senate, where companion legislation has gathered bipartisan co-sponsors but faces a congested legislative calendar.
Senate leaders have not announced an official date for a floor vote, though momentum from the House vote increases political pressure on key holdouts.
If signed into law, the Office of Congressional Ethics will face the administrative task of auditing financial filings and overseeing the creation of hundreds of new blind trusts.
Market observers are also watching to see if a mandatory divestment window triggers notable selling volume in mega-cap technology and healthcare stocks frequently held by congressional members.
